Sareum Holdings Past Earnings Performance

Past criteria checks 0/6

Sareum Holdings's earnings have been declining at an average annual rate of -29%, while the Pharmaceuticals industry saw earnings growing at 13.1% annually. Revenues have been declining at an average rate of 20.3% per year.

Key information

-29.0%

Earnings growth rate

-24.2%

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate-20.3%
Return on equity-161.8%
Net Marginn/a
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Sareum Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:RYH0 Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-350
31 Mar 240-450
31 Dec 230-450
30 Sep 230-440
30 Jun 230-340
31 Mar 230-340
31 Dec 220-330
30 Sep 220-230
30 Jun 220-230
31 Mar 220-220
31 Dec 210-220
30 Sep 210-220
30 Jun 210-120
31 Mar 210-110
31 Dec 200-110
30 Sep 200-110
30 Jun 200-110
31 Mar 200-110
31 Dec 190-110
30 Sep 190-120
30 Jun 190-120
31 Mar 190-120
31 Dec 180-220
30 Sep 180-120
30 Jun 180-120
31 Mar 180-120
31 Dec 170-120
30 Sep 170010
30 Jun 170010
31 Mar 170010
31 Dec 160010
30 Sep 160-110
30 Jun 160-110
31 Mar 160-110
31 Dec 150-110
30 Sep 150-110
30 Jun 150-110
31 Mar 150-110
31 Dec 140-110
30 Sep 140-110
30 Jun 140-110
31 Mar 140-110

Quality Earnings: RYH0 is currently unprofitable.

Growing Profit Margin: RYH0 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RYH0 is unprofitable, and losses have increased over the past 5 years at a rate of 29% per year.

Accelerating Growth: Unable to compare RYH0's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RYH0 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (28.7%).


Return on Equity

High ROE: RYH0 has a negative Return on Equity (-161.78%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies